Showing results (131-140 of 150) with videos related to

Sort By:
Pageof 15
The Lancet. Rheumatology|January 24, 2024
Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept studyBenjamin A Fisher, Antonia Szanto, Wan-Fai Ng, et al.
Cell Reports|August 29, 2019
Molecular Portraits of Early Rheumatoid Arthritis Identify Clinical and Treatment Response PhenotypesMyles J Lewis, Michael R Barnes, Kevin Blighe, et al.
Annals of the Rheumatic Diseases|December 25, 2017
Effect of rituximab on a salivary gland ultrasound score in primary Sjögren's syndrome: results of the TRACTISS randomised double-blind multicentre substudyBenjamin A Fisher, Colin C Everett, John Rout, et al.
RMD Open|June 7, 2019
Pain and depression are associated with both physical and mental fatigue independently of comorbidities and medications in primary Sjögren's syndromeKate L Hackett, Kristen Davies, Jessica Tarn, et al.
RMD Open|August 6, 2016
Fatigue in primary Sjögren's syndrome is associated with lower levels of proinflammatory cytokinesNadia Howard Tripp, Jessica Tarn, Andini Natasari, et al.
Rheumatology (Oxford, England)|October 30, 2015
Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome RegistryClare Oni, Sheryl Mitchell, Katherine James, et al.
Arthritis Care & Research|December 20, 2016
Subjective and Objective Measures of Dryness Symptoms in Primary Sjögren's Syndrome: Capturing the DiscrepancyOriana M Bezzina, Peter Gallagher, Sheryl Mitchell, et al.
Plos One|December 24, 2015
A Transcriptional Signature of Fatigue Derived from Patients with Primary Sjögren's SyndromeKatherine James, Shereen Al-Ali, Jessica Tarn, et al.
The Lancet. Rheumatology|January 22, 2024
Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trialsFelice Rivellese, Alessandra Nerviani, Giovanni Giorli, et al.
Annals of the Rheumatic Diseases|June 17, 2025
Primary Sjögren's Disease: a review of unmet need, outcome measures, therapeutic advances and health economic impacts. Lessons from the NEw Clinical Endpoints in primary Sjögren's Syndrome: an Interventional Trial based on stratifYing patients (NECESSITY) Innovative Health Initiative (IHI)Simon J Bowman, Raphaele Seror, Raphael Porcher, et al.
Pageof 15